Professional Master's in Immunobiological Technology
The Professional Master's in Immunobiological Technology - MPTI, from the Institute of Technology on Immunobiologicals - Bio-Manguinhos aims to train qualified professionals to work in the development of new technologies and improvement of immunobiological production processes. In addition, the MPTI also aims to train managers focused on the optimization of production processes, quality control and assurance, cost reduction and the implementation of continuous improvement processes.
The training of the MPTI professional is directed in order that the master's student acquires knowledge in several areas so that, in the end, he has a multidisciplinary view of the areas of Development, Production, Quality and Management for Immunobiologicals.
The course consists of theoretical and practical classes, seminars and the development of experimental activity of the master's project, which will enable training and updating in relation to advances in Technological Innovation in biotechnological processes applied to Immunobiologicals. The main objective of the master's degree is the integration of theory with practice, rethinking techniques and processes to lead students to the analysis, planning and implementation of new products and solutions.
The research lines are: Process and Quality Control; Technological Development of Products and Processes; and Management.
Brazil needs technical knowledge in the area of biotechnology that is applicable in the generation of knowledge and profitable productive activities.
The Bio-Manguinhos industrial park is one of the largest in Latin America, intended for the production of immunobiologicals, meeting the standards of Good Laboratory, Manufacturing and Biosafety Practices. The activities permeate the fields of innovation, development and production of strategic inputs that expand access to health by the Brazilian population and make the country more self-sufficient.
To meet the growing demands of the Ministry of Health's programs, Bio-Manguinhos continually invests in adapting, modernizing, expanding its physical infrastructure and training its human resources. The level of excellence is also due to investments in innovative solutions, internally and externally, through technological partnerships with national and international institutions in the public and private sectors.
In view of the above reasons, the Master's in Technology in Immunobiologicals has a growing demand for candidates interested in obtaining a professional Master's degree in Vaccine Technologies. It is worth mentioning the support and sponsorship of Bio-Manguinhos, which has been offering a free course and scholarships to students without an employment relationship.